For example, the phosphorylation of Ser129 of SYN is more frequent in PD than in normal healthy brain, therefore, it can be considered as an unwanted factor, consequently, the prevention of this modification could serve as drug target [82]. This evidence concerns the gene FYN and Parkinson disease.